Fresenius Medical Care AG & Co KGaA ST buy fenjal
Summary
This prediction ended on 20.02.19 with a price of €71.18. The prediction had a final performance of 24.05%. fenjal has 50% into this predictionFresenius Medical Care is a leading global provider of dialysis products, services and care, particularly for patients with chronic kidney disease. It operates in over 120 countries and cares for over 345,000 patients worldwide. The company specializes in renal care, manufacturing and distributing products related to dialysis and providing clinical care as well as education and support services for patients with kidney disease. Fresenius Medical Care has been listed on the Frankfurt Stock Exchange since 1996 and on the New York Stock Exchange since 1997. Its symbol, FMCQF, represents its over-the-counter (OTC) stock symbol in the United States.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Fresenius Medical Care AG & Co KGaA ST | -0.858% | -0.858% | -21.962% | -47.037% |
iShares Core DAX® | 1.663% | 6.945% | 18.807% | 17.549% |
iShares Nasdaq 100 | 1.261% | 4.883% | 23.667% | 36.206% |
iShares Nikkei 225® | 0.654% | 10.007% | 15.047% | 9.552% |
iShares S&P 500 | 1.403% | 4.350% | 23.305% | 38.641% |
According to fenjal what are the pros and cons of Fresenius Medical Care AG & Co KGaA ST for the foreseeable future?
Pros
Cons
Comments by fenjal for this prediction
In the thread Fresenius Medical Care AG & Co KGaA ST diskutieren
fenjal stimmt dem Sentiment von 'Buy' zu
fenjal stimmt am 22.12.2018 dem Buy-Gesamtsentiment mit dem Kursziel 89.0€ zu.
Stopped prediction by fenjal for Fresenius Medical Care AG & Co KGaA ST
Fresenius Medical Care AG & Co KGaA ST
11.10.23
11.10.24
12.12.23
Fresenius Medical Care AG & Co KGaA ST
13.11.22
13.12.22
14.12.22
Fresenius Medical Care AG & Co KGaA ST
21.03.17
25.04.17
25.04.17
Fresenius Medical Care AG & Co KGaA ST
09.01.17
09.03.17
09.03.17